Table of Contents
Introduction
Infectious diseases pose significant challenges to public health worldwide. The detection and diagnosis of these diseases rely on various tests that identify pathogens or their components. This article outlines key tests used in the diagnosis of infectious diseases, focusing on their methodologies, sensitivity, specificity, and applications.
Diagnostic Tests for Infectious Diseases
Molecular Tests
Molecular tests, such as Polymerase Chain Reaction (PCR), are prevalent due to their high sensitivity and specificity. Reverse Transcription PCR (RT-PCR) is frequently used for viral infections, including influenza and SARS-CoV-2. Quantitative PCR (qPCR) allows for the estimation of viral load, yielding numerical data expressed in copies per milliliter (copies/mL).
Serological Tests
These tests detect antibodies (IgM, IgG) or antigens in the blood, indicating current or past infections. Sensitivity and specificity can vary, typically ranging from 70% to 95%. Enzyme-Linked Immunosorbent Assays (ELISA) are standard for diseases like HIV and hepatitis B.
Culturing Techniques
Microbial culturing remains a gold standard for certain infections. This method isolates the pathogen, allowing for identification and antibiotic susceptibility testing. Culturing can take 24 hours to several weeks, depending on the microorganism.
Antigen Detection
Antigen detection tests identify pathogen proteins and offer rapid results. Lateral flow immunoassays and immunofluorescence assays are examples. The sensitivity of these tests can range from 50% to 90%, depending on the infection stage and sample type.
Microscopy and Staining
Microscopic examination and staining techniques, such as Gram staining, are fundamental for bacterial infections. These methods offer quick results and can differentiate between major bacterial groups. Their accuracy is contingent on sample quality and technician expertise.
Rapid Diagnostic Tests (RDTs)
RDTs provide quick results at the point of care, useful in resource-limited settings. These tests typically detect antigens or antibodies. While highly portable and easy to use, their sensitivity may be lower (60%-85%) than laboratory-based tests.
Company Solutions
Several companies offer proprietary solutions for Infectious Disease Testing:
- Roche Diagnostics: Offers cobas PCR tests with high throughput, boasting over 95% sensitivity for viral detection.
- Abbott Laboratories: Known for its PANBIO COVID-19 RDT, with sensitivity ranging from 60% to 90% based on clinical trials.
- Becton, Dickinson and Company: Provides BD Veritor System, a rapid antigen detection test for multiple respiratory viruses.
- Qiagen: Qiagen offers QIAsymphony, an advanced system for nucleic acid purification and PCR assay setup, yielding rapid and reliable results.
References
- Centers for Disease Control and Prevention (CDC). Guidelines for Laboratory Testing.
- World Health Organization (WHO). Diagnostic Testing for SARS-CoV-2.
- Clinical Microbiology Reviews. Techniques in Molecular Microbiology.
- Journal of Clinical Virology. Advances in Rapid Diagnostic Testing.